loading

Aclaris Therapeutics Inc Azioni (ACRS) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
86.35%
2.398
17.57 9.282 1.869 2.528
Cost Of Revenue
11.59%
0.809
0.725 0.848 1.042 0.808
Gross Profit
90.57%
1.589
16.84 8.434 0.827 1.72
Operating Expenses
1.78%
20.52
20.89 40.01 32.64 31.64
Benefits Costs and Expenses
0.46%
19.34
19.43 40.86 33.68 30.69
Costs And Expenses
1.33%
21.33
21.62 40.86 33.68 32.45
Operating Income/Loss
367.78%
-18.93
-4.047 -31.58 -31.82 -29.92
Income/Loss From Continuing Operations Before Tax
811.79%
-16.94
-1.858 -31.58 -29.57 -28.16
Income Tax Expense/Benefit
100.00%
-
-0.367 - - -
Income/Loss From Continuing Operations After Tax
1,036%
-16.94
-1.491 -29.26 -29.57 -28.16
Net Income/Loss
1,036%
-16.94
-1.491 -29.26 -29.57 -28.16
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
19,845%
71.07
0.3564 70.81 70.63 66.87
Diluted Average Shares
19,845%
71.07
0.3564 70.81 70.63 66.87
Basic Earnings Per Share
1,100%
-0.24
-0.02 -0.41 -0.42 -0.42
Diluted Earnings Per Share
1,100%
-0.24
-0.02 -0.41 -0.42 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research LH
$228.61
price up icon 0.72%
$161.88
price up icon 2.40%
$136.02
price up icon 1.51%
diagnostics_research WAT
$368.16
price up icon 2.09%
diagnostics_research MTD
$1,230.74
price up icon 2.05%
$412.26
price up icon 0.79%
Capitalizzazione:     |  Volume (24 ore):